These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 465359)

  • 21. Significance of copper level in serum and routine laboratory parameters in estimation of outspreading of Hodgkin's lymphoma.
    Jamakovic M; Baljic R
    Med Arch; 2013; 67(3):185-7. PubMed ID: 23848039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD).
    Hefti JE; Blumberg A; Marti HR
    Clin Nephrol; 1983 May; 19(5):232-5. PubMed ID: 6851263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavior of total serum complement in Hodgkin's disease and other malignant lymphomas.
    ROTTINO A; LEVY AL
    Blood; 1959 Mar; 14(3):246-54. PubMed ID: 13628822
    [No Abstract]   [Full Text] [Related]  

  • 25. [Red cell system and selected red cell enzymes in men occupationally exposed to mercury vapours].
    Zabiński Z; Rutowski J; Moszczyński P; Dabrowski Z
    Przegl Lek; 2006; 63 Suppl 7():74-83. PubMed ID: 17784549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of copper on red cell enzyme activities.
    Boulard M; Blume KG; Beutler E
    J Clin Invest; 1972 Feb; 51(2):459-61. PubMed ID: 4257805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human red blood cell loading with hexokinase-inactivating antibodies. An in vitro model for enzyme deficiencies.
    Magnani M; Rossi L; Bianchi M; Serafini G; Stocchi V
    Acta Haematol; 1989; 82(1):27-34. PubMed ID: 2505471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porphobilinogen deaminase activity in malignant proliferative disorders of the lymphatic system and bone marrow.
    Zawirska B; Usnarska-Zubkiewicz L; Gamian E
    Patol Pol; 1993; 44(1):13-7. PubMed ID: 8488077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hexokinase isozymic pattern during red cell aging.
    Magnani M; Stocchi V; Dachà M; Canestrari F; Fornaini G
    FEBS Lett; 1980 Nov; 120(2):264-6. PubMed ID: 7439400
    [No Abstract]   [Full Text] [Related]  

  • 31. Iron, copper, and zinc liver tissue levels in patients with malignant lymphomas.
    Roguljić A; Roth A; KolariC K; Maricić Z
    Cancer; 1980 Aug; 46(3):565-9. PubMed ID: 6994869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte production and survival in Rauscher murine leukemia virus-infected BABL/c mice.
    de Both NJ; Kwak E; Klootwijk-van Dijke E
    Cancer Res; 1980 Nov; 40(11):4270-5. PubMed ID: 7471066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between erythrocyte hexokinase in cancer patients and red cell age.
    Canestrari F; Dachà U; Giacchi R; Magnani M; Stocchi V; Palma F; Piacentini G; Dachà M
    Tumori; 1983 Apr; 69(2):89-93. PubMed ID: 6679438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory properties of human erythrocyte hexokinase during cell ageing.
    Fornaini G; Magnani M; Fazi A; Accorsi A; Stocchi V; Dachà M
    Arch Biochem Biophys; 1985 Jun; 239(2):352-8. PubMed ID: 3873907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Minckler TM; Mosier B; Taylor GH
    Cancer; 1968 Apr; 21(4):743-55. PubMed ID: 4868473
    [No Abstract]   [Full Text] [Related]  

  • 36. Red cell metabolism in the newborn infant. V. Glycolytic intermediates and glycolytic enzymes.
    Oski FA
    Pediatrics; 1969 Jul; 44(1):84-91. PubMed ID: 4307568
    [No Abstract]   [Full Text] [Related]  

  • 37. An examination of the age-related patterns of decay of the hexokinases of human red cells.
    Rogers PA; Fisher RA; Harris H
    Clin Chim Acta; 1975 Dec; 65(3):291-8. PubMed ID: 1204220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes.
    Magnani M; Rossi L; Bianchi M; Serafini G; Zocchi E; Laguerre M; Ropars C
    Biotechnol Appl Biochem; 1989 Oct; 11(5):439-44. PubMed ID: 2803567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum proteins in Hodgkin's disease and malignant lymphoma.
    ARENDS T; COONRAD EV; RUNDLES RW
    Am J Med; 1954 Jun; 16(6):833-41. PubMed ID: 13158372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.